What is Assembly Biosciences's investing cash flow?

Assembly Biosciences (ASMB) reported investing cash flow of -$5.38M in Q1 2026.

How has Assembly Biosciences's investing cash flow changed year-over-year?

Assembly Biosciences's investing cash flow decreased by 181.7% year-over-year, from $6.59M to -$5.38M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Assembly Biosciences ASMB Investing Cash Flow

Investing Cash Flow at other companies

Arrowhead ResearchARWR

-$894.28M-113%

ALN

Alnylam PharmaceuticalsALNY

-$25.54M-122%

Avalo TherapeuticsAVTX

$25.51M—

Arbutus Biopharma CorporationABUS

$2.2M-80.6%

Vir Biotechnology, Inc.VIR

$11.84M-90.7%

Maravai LifeSciences Holdings, Inc.MRVI

-$4.44M+80.8%

Other financials

Income statement

See full

Revenue$8.2M-12.8%

Operating income-$11.4M-14.4%

Net income-$9.1M-3.0%

EPS (diluted)-$0.54+53.8%

Balance sheet

See full

Cash & equivalents$31.1M+32.9%

Total debt$2.5M-17.5%

Total equity$198.6M+632%

Total assets$235.5M+138%

Cash flow

See full

Operating cash flow-$22.1M+5.7%

CapEx$19.0K—

Free cash flow-$22.1M+5.6%

Valuation

See full

Market cap$480.77M+262%

Enterprise value$452.14M+302%

P/S6.8×+2.6×

Profitability

See full

Operating margin-116.8%-26.1pp

Net margin-103.6%-22.7pp

FCF margin-150%-231pp

Returns & leverage

See full

Return on equity-36.9%-15.1pp

Debt / equity0×-0.1×

Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's investing cash flow?: Assembly Biosciences (ASMB) reported investing cash flow of -$5.38M in Q1 2026.
How has Assembly Biosciences's investing cash flow changed year-over-year?: Assembly Biosciences's investing cash flow decreased by 181.7% year-over-year, from $6.59M to -$5.38M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.